(Q39436084)

12 September 2017

Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer (English)

1 reference

12 September 2017

10

1 reference

12 September 2017

Juan P Cerliani

1

1 reference

12 September 2017

Silvia I Vanzulli

2

1 reference

12 September 2017

Cecilia Pérez Piñero

3

1 reference

12 September 2017

María C Bottino

4

1 reference

12 September 2017

Ana Sahores

5

1 reference

12 September 2017

Myriam Nuñez

6

1 reference

12 September 2017

Romina Varchetta

7

1 reference

12 September 2017

Rubén Martins

8

1 reference

12 September 2017

Eduardo Zeitlin

9

1 reference

12 September 2017

Alfredo A Molinolo

11

1 reference

12 September 2017

Claudia Lanari

12

1 reference

12 September 2017

Caroline A Lamb

13

1 reference

12 September 2017

language of work or name

English

0 references

publication date

29 November 2011

1 reference

Breast Cancer Research and Treatment

12 September 2017

1 reference

12 September 2017

133

1 reference

12 September 2017

997-1008

1 reference

12 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1883-6

12 September 2017

0 references

cites work

Expression of fibroblast growth factor-1 (FGF-1), FGF-2 and FGF receptor-1 in a human salivary-gland adenocarcinoma cell line: evidence of growth

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Expression of fibroblast growth factor-2 and fibroblast growth factor receptor-1 in thyroid diseases: difference between neoplasms and hyperplastic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Fibroblast growth factors, their receptors and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Potential for targeting the fibroblast growth factor receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Attenuation and loss of hormonal modulation of KGF (FGF-7)/KGF receptor expression and mitogenesis during mammary tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Protein kinase expression during murine mammary development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Hormone action in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Novel human breast cancer cell lines IBH-4, IBH-6, and IBH-7 growing in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

FGFR signaling promotes the growth of triple-negative and basal-like breast cancer cell lines both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Comprehensive profiling of 8p11-12 amplification in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

FGFR2 protein expression in breast cancer: nuclear localisation and correlation with patient genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/molecular parameters and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Genetic susceptibility loci for breast cancer by estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1883-6

Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer

21 January 2018

1 reference

12 December 2020

The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer

1 reference

12 December 2020

Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.

1 reference

12 December 2020

Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer

1 reference

12 December 2020

The fibroblast growth factor receptor, FGFR3, forms gradients of intact and degraded protein across the growth plate of developing bovine ribs

1 reference

12 December 2020

Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer

1 reference

12 December 2020

Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele

1 reference

12 December 2020

Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma

1 reference

12 December 2020

10.1007/S10549-011-1883-6

Identifiers

DOI

1 reference

12 September 2017

0 references

1 reference